New discoveries have identified immuno-oncology targets and therapies; using the patients’ own immune system to recognize and destroy tumors. This specific targeting shows tremendous promise, ameliorating the extensive damage to the body that many conventional therapies incur. Our therapeutic candidates have the potential to significantly improve the clinical outcomes of patients with cancer. Providing better quality of life and increasing long-term survival.